7-92528434-A-G
Variant summary
Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_000466.3(PEX1):c.2T>C(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000107 in 1,587,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000466.3 start_lost
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 1A (Zellweger)Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, Ambry Genetics
- Heimler syndrome 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics
- peroxisome biogenesis disorder 1BInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000466.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX1 | NM_000466.3 | MANE Select | c.2T>C | p.Met1? | start_lost | Exon 1 of 24 | NP_000457.1 | ||
| PEX1 | NM_001282677.2 | c.2T>C | p.Met1? | start_lost | Exon 1 of 23 | NP_001269606.1 | |||
| PEX1 | NM_001282678.2 | c.-658T>C | 5_prime_UTR | Exon 1 of 24 | NP_001269607.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX1 | ENST00000248633.9 | TSL:1 MANE Select | c.2T>C | p.Met1? | start_lost | Exon 1 of 24 | ENSP00000248633.4 | ||
| PEX1 | ENST00000428214.5 | TSL:1 | c.2T>C | p.Met1? | start_lost | Exon 1 of 23 | ENSP00000394413.1 | ||
| PEX1 | ENST00000438045.5 | TSL:2 | c.2T>C | p.Met1? | start_lost | Exon 1 of 21 | ENSP00000410438.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 4AN: 199938 AF XY: 0.00000913 show subpopulations
GnomAD4 exome AF: 0.0000111 AC: 16AN: 1435574Hom.: 0 Cov.: 31 AF XY: 0.00000983 AC XY: 7AN XY: 711776 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74306 show subpopulations
ClinVar
Submissions by phenotype
Zellweger spectrum disorders Pathogenic:2
This sequence change affects the initiator methionine of the PEX1 mRNA. The next in-frame methionine is located at codon 209. This variant is present in population databases (rs766020928, gnomAD 0.01%). Disruption of the initiator codon has been observed in individuals with Zellweger spectrum disorder (PMID: 21031596, 28468868). ClinVar contains an entry for this variant (Variation ID: 371746). For these reasons, this variant has been classified as Pathogenic.
Peroxisome biogenesis disorder 1A (Zellweger) Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Peroxisome biogenesis disorder type 1A Pathogenic:1
Peroxisome biogenesis disorder Pathogenic:1
Variant summary: PEX1 c.2T>C (p.Met1?) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 199938 control chromosomes (gnomAD). c.2T>C has been reported in the literature in multiple homozygous individuals affected with Zellweger Syndrome (ie. Ebberink_2010, Ghosh_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Peroxisome biogenesis disorder 1B;C4551980:Heimler syndrome 1;C4721541:Peroxisome biogenesis disorder 1A (Zellweger) Pathogenic:1
Peroxisome biogenesis disorder 1B Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at